semaglutide injection risks & Mental Health Semaglutide for Weight Loss

In the largest comparative effectiveness study of tirzepatide (Mounjaro) and semaglutide (Ozempic) for weight loss using real-world data now published in JAMA Internal Medicine Truveta Research found that patients with overweight or obesity taking tirzepatide were three times more likely to achieve 15% weight loss than those taking semaglutide

Read more: bit.ly/46uQ5dg #GLP1 #FDAgreenlist #healthcare

Try Hiphenolic

The Semaglutide Market was valued at USD 27.79 Billion in 2025 and is expected to reach USD 72.34 Billion by 2035, growing at a CAGR of 10.04%.

PlexusDx offers compounded semaglutide injections starting at $149 per month, providing access to GLP-1 therapy without insurance requirements

Clinical data supports GLP-1 receptor agonists for weight loss, though outcomes vary by individual metabolic factors and adherence